Cerebrospinal Fluid Amino Acid Profiling of Pediatric Cases with Tuberculous Meningitis

Shayne Mason1, Carolus J Reinecke1, Regan Solomons2

  • 1Faculty of Natural Sciences, Centre for Human Metabolomics, North-West University, Potchefstroom, South Africa.

Frontiers in Neuroscience
|October 12, 2017
PubMed

Insights

Tackling tuberculous meningitis (TBM) in children, this study identified five key amino acids in cerebrospinal fluid (CSF) using gas chromatography-mass spectrometry. These biomarkers show promise for earlier TBM diagnosis and treatment.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Biochemistry

Background:

  • Tuberculosis remains a major global health threat, particularly in Africa.
  • Pediatric tuberculous meningitis (TBM) is a severe neurological manifestation with high morbidity and mortality.
  • Early diagnosis of TBM is challenging due to non-specific symptoms, leading to delayed treatment and poor outcomes.

Purpose of the Study:

  • To investigate the biochemical profile of cerebrospinal fluid (CSF) in pediatric TBM cases.
  • To identify potential biomarkers for improving early diagnosis of TBM.
  • To elucidate the neuroinflammatory pathways involved in pediatric TBM.

Main Methods:

  • Analysis of amino acid profiles in CSF from pediatric TBM patients and controls.
  • Utilized gas chromatography-mass spectrometry (GC-MS) for sensitive and accurate analysis.
  • Employed stringent quality assurance and statistical methods for biomarker identification.

Main Results:

  • Five amino acids—alanine, asparagine, glycine, lysine, and proline—were significantly elevated in TBM cases.
  • Elevated alanine linked to increased CSF lactate; lysine associated with lipid peroxidation.
  • Other amino acids implicated in neurotransmission, glutamate-glutamine cycling, and ammonia metabolism.

Conclusions:

  • CSF amino acid profiling via GC-MS offers a promising avenue for early TBM diagnosis.
  • Identifying these biomarkers can facilitate timely treatment initiation.
  • Further research into CSF biochemistry can improve management of pediatric TBM.